Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study
- PMID: 19224892
- DOI: 10.1136/adc.2008.143594
Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study
Abstract
Objective: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in obese youth. Lifestyle intervention was demonstrated to improve NAFLD but follow-up studies after end of intervention are lacking. Furthermore the necessary degree of overweight reduction for improvement of NAFLD remains unknown.
Methods: We examined standard deviation score of body mass index (SDS-BMI) and transaminases in 152 obese children with NAFLD diagnosed by ultrasound at baseline, at the end of a 1-year intervention and 2 years after baseline. Within-subject changes of these parameters were compared by participation in the intervention based on physical activity, nutrition education and behaviour therapy.
Results: In contrast to 43 children without lifestyle intervention, participation in lifestyle intervention (n = 109) was associated with a significant decrease of transaminases and overweight 1 and 2 years after baseline (1 year: alanine transaminase (ALT) -10 U/l (-14 to -6); aspartate transaminase (AST) -5 U/l (-7 to -3); SDS-BMI -0.23 (-0.30 to -0.16); 2 years: ALT -9 U/l (-12 to -6); AST -6 U/l (-7 to -4); SDS-BMI -0.30 (-0.37 to -0.22); data as mean changes and 95% confidence interval compared to baseline). Any degree of overweight reduction was associated with a significant decrease of NAFLD prevalence. The greatest decrease of NAFLD prevalence (1 year: -89% (95% CI -72% to -100%); 2 years: -94% (95% CI -83% to -100%)) was observed in children with the greatest overweight reduction (SDS-BMI decrease >0.5).
Conclusions: Multidisciplinary lifestyle intervention is effective to improve NAFLD even in the 1-year follow-up after the end of intervention. A minimal reduction of overweight led to an improvement of NAFLD.
Trial registration number: NCT00435734.
Similar articles
-
Association between leptin and transaminases: 1-year follow-up study in 180 overweight children.Metabolism. 2009 Apr;58(4):497-503. doi: 10.1016/j.metabol.2008.11.007. Metabolism. 2009. PMID: 19303970
-
Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis.J Clin Endocrinol Metab. 2012 Jun;97(6):2143-50. doi: 10.1210/jc.2012-1221. Epub 2012 Mar 21. J Clin Endocrinol Metab. 2012. PMID: 22438225 Clinical Trial.
-
[Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle].Endocrinol Nutr. 2012 Jun-Jul;59(6):346-53. doi: 10.1016/j.endonu.2012.05.002. Epub 2012 Jun 19. Endocrinol Nutr. 2012. PMID: 22717644 Clinical Trial. Spanish.
-
Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.Minerva Gastroenterol Dietol. 2010 Jun;56(2):159-67. Minerva Gastroenterol Dietol. 2010. PMID: 20485253 Review.
-
[Non-alcoholic fatty liver disease in children: a new complication of obesity].Ned Tijdschr Geneeskd. 2008 Nov 8;152(45):2443-7. Ned Tijdschr Geneeskd. 2008. PMID: 19051794 Review. Dutch.
Cited by
-
Lifestyle intervention in childhood obesity: changes and challenges.Nat Rev Endocrinol. 2013 Oct;9(10):607-14. doi: 10.1038/nrendo.2013.149. Epub 2013 Jul 30. Nat Rev Endocrinol. 2013. PMID: 23897171 Review.
-
Girls and Boys Have a Different Cardiometabolic Response to Obesity Treatment.Front Endocrinol (Lausanne). 2018 Oct 2;9:579. doi: 10.3389/fendo.2018.00579. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30333791 Free PMC article.
-
Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention.World J Gastroenterol. 2009 Dec 28;15(48):6017-22. doi: 10.3748/wjg.15.6017. World J Gastroenterol. 2009. PMID: 20027672 Free PMC article.
-
Clinically Meaningful Body Mass Index Change Impacts Pediatric Nonalcoholic Fatty Liver Disease.J Pediatr. 2022 Nov;250:61-66.e1. doi: 10.1016/j.jpeds.2022.07.004. Epub 2022 Jul 11. J Pediatr. 2022. PMID: 35835225 Free PMC article.
-
Childhood obesity and cardiovascular disease: links and prevention strategies.Nat Rev Cardiol. 2011 Jun 14;8(9):513-25. doi: 10.1038/nrcardio.2011.86. Nat Rev Cardiol. 2011. PMID: 21670745 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases